Latest Regulatory News

Dimerix has activated the first clinical trial site in Japan for its pivotal Phase 3 ACTION3 study targeting FSGS, triggering a significant milestone payment from its Japanese partner FUSO Pharmaceutical.

NRW Holdings’ subsidiary Primero Group has landed a $157 million contract from Rio Tinto to deliver critical infrastructure at Hope Downs in Western Australia, extending their longstanding partnership.

The Arkansas Oil & Gas Commission has approved a 2.5% lithium royalty for brine projects, providing Pantera Lithium with regulatory clarity and a competitive fiscal framework that enhances its Smackover Project’s commercial prospects.

Lord Resources Limited has announced a pro-rata non-renounceable entitlement issue to raise approximately $1.39 million, primarily to fund exploration at its Ilgarari Copper Project. The offer presents both opportunity and risk for shareholders amid ongoing funding needs and exploration uncertainties.

Chorus Limited’s 2024 fibre regulatory report reveals a stable $5.9 billion asset base and revenue close to the maximum allowed, with a $153.5 million wash-up balance carried forward.

Pacific Edge Limited has launched a NZ$20 million capital raise to bolster its cash reserves amid the loss of Medicare coverage for its bladder cancer diagnostic tests, aiming to accelerate US market adoption and support new product development.

Pacific Edge Limited reported a resilient FY25 performance despite losing Medicare coverage for its Cxbladder tests in the US, announcing a $20 million equity raise to support commercialization and growth.

CZR Resources has won overwhelming shareholder approval to sell its Robe Mesa Iron Ore Project to a Rio Tinto-Mitsui joint venture for approximately A$75 million, setting the stage for a significant portfolio reshuffle.

Aston Minerals Limited shares will be suspended from trading following court approval of its acquisition by Torque Metals Limited. This marks a significant step in the consolidation of mining assets in Western Australia.

Rare Foods Australia Limited has requested an immediate suspension of its shares on the ASX, paving the way for its voluntary removal from the exchange next month. This move follows shareholder approval earlier this year.

Wellnex Life Limited has had its trading suspension lifted following its response to ASX queries related to a recent shareholder letter, reopening market access to its shares.

Wellnex Limited has withdrawn its recent announcement referencing a SP Angel research report containing forward-looking financial information, clarifying it does not endorse the projections.